Experience

SpyBiotech

• United Kingdom
• Biotechnology Research
• 1 - 100 Employee

• Senior Scientist

  • Dec 2021 - Present



University of Oxford

• United Kingdom
• Research Services
• 700 & Above Employee

• Postdoctoral Researcher and Laboratory manager

  • Oct 2008 - Dec 2021

  My current research focusses on HIV-1 vaccine design using recombinant HIV-1 Env proteins as part of the EAVI consortium and the EHVA consortium both funded by the Horizons 2020 european union. Adaptation of the HIV-1 vaccine strategies have resulted in a side project looking at SARS-CoV-2 vaccine development with various collaborators in the University of Oxford and the wider research community. Previously I worked on cell-to-cell spread of HIV-1 from T-cells to macrophages, resulting in a joint first author paper published in Cell, Host and Microbe. Alongside my research I am also responsible for the day-to-day running of the Sattentau lab which involves the induction and training of all new laboratory members; project management of students; ensuring the laboratory is compliant in terms of health and safety paperwork and liaising with departmental support staff to ensure the smooth running of the laboratory. I also manage the departmental containment level 3 laboratory for work on replication-competent HIV-1 and SARS-CoV-2. At the beginning of the Covid19 pandemic I was instrumental in commissioning the facility for SARS-CoV2 work and am responsible for the ongoing training of users and maintenance of the facility. I am currently co-chair of the laboratory managers association, a member of the Departmental Safety Committee and a member of the Departmental Green Group. Previously I was a member of the Departmental Athena Swan Committee and the Post-doc Association. https://sattentau.path.ox.ac.uk/content/dr-rebecca-moore https://www.research.ox.ac.uk/Researchers/rebecca-moore Show less



HIV Drug Resistance Program, National Institutes of Health, National Cancer Institute

• Frederick, Maryland, United States

• Visiting NIH Postdoctoral Research Fellow

  • Sep 2005 - Sep 2008

  Characterization of the interactions between HIV-1 Vif and the APOBEC3 proteins using standard virological and molecular biology techniques. Characterization of the interactions between HIV-1 Vif and the APOBEC3 proteins using standard virological and molecular biology techniques.



Imperial College London

• Research Services
• 700 & Above Employee

• Wellcome Prize Post-doctoral Research Fellow

  • Dec 2002 - Dec 2004

  Analysis of the effects of APOBEC3 proteins on Prototype Foamy Virus, and development of Prototype Foamy Virus and Adenovirus gene therapy vectors using standard virological and molecular biology techniques. Analysis of the effects of APOBEC3 proteins on Prototype Foamy Virus, and development of Prototype Foamy Virus and Adenovirus gene therapy vectors using standard virological and molecular biology techniques.